
Dnipac-P Tablet
Marketer
Gurgrace Pharmaceuticals
Salt Composition
Aceclofenac (100mg) + Paracetamol (325mg)
Overview Dnipac-P Tablet
Panacea-P tablets offer pain relief. This medication diminishes pain and inflammation associated with conditions such as rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis. It can also alleviate muscle aches, back pain, dental pain, and ear or throat discomfort. Panacea-P tablets can be ingested with or without food, consistently as directed by your physician. Dosage and frequency may be adjusted based on individual pain levels and needs. Never exceed the prescribed dosage or duration. Potential side effects include nausea, vomiting, abdominal pain, appetite loss, indigestion, and diarrhea. Report any persistent or bothersome side effects to your doctor, who can explore alternative treatments or dosage modifications. Panacea-P tablets aren't universally suitable. Inform your doctor about any pre-existing heart, kidney, liver conditions, or stomach ulcers before commencing treatment. Disclose all other medications to ensure safe usage. Pregnant or breastfeeding individuals should consult their doctor prior to using Panacea-P tablets.
Uses of Dnipac-P Tablet
Analgesia
Major Benefits of Dnipac-P Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dnipac-P Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Dnipac-P Tablet:
- Nausea
- Vomiting
- Stomach pain/epigastric pain
- Loss of appetite
- Heartburn
- Diarrhea
How to use Dnipac-P Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Dnipac-P Tablets. Ingest the tablet whole; avoid chewing, crushing, or breaking it. While Dnipac-P Tablets can be taken with or without food, consistent timing is recommended.
How Dnipac-P Tablet works:
Aceclofenac and Paracetamol, the components of Dnipac-P Tablet, selectively inhibit the production of pain, fever, and inflammatory mediators, thus reducing symptoms such as redness and swelling.
SAFETY ADVICE
AlcoholUNSAFE
Combining Dnipac-P Tablet with alcohol is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Using Dnipac-P Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against potential dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Dnipac-P Tablet with breastfeeding is lacking. Seek medical advice.
DrivingUNSAFE
Taking Dnipac-P Tablets might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should use Dnipac-P Tablets cautiously, potentially requiring dosage modification under medical supervision. Dnipac-P Tablets are contraindicated in individuals with severe kidney disease.
LiverCAUTION
Caution is advised when prescribing Dnipac-P tablets to individuals with hepatic impairment; dosage modification may be necessary. Medical consultation is recommended. Dnipac-P tablets are contraindicated in patients experiencing severe or active liver disease.
What if you forget to take Dnipac-P Tablet :
Should you forget a Dnipac-P Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dnipac-P Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
